物理性质
- 熔点-123 °C
- 沸点18.6±3.0 °C at 760 mmHg
- 闪点-40.0±0.0 °C
- 密度0.7±0.1 g/cm3
- PH:5 (10g/l, H2O, 20°C)
- pKa:13.57(at 25°C)
- PSA:17.07
- LogP:-0.16
- 折射率1.315
- 蒸汽压964.5±0.0 mmHg at 25°C
- 溶解性Alcohols: Soluble
- 敏感性空气敏感
- 外观形态白色至类白色溶液
- 储存条件2-8°C
- 产品应用一,主要用于制备醋酸,醋酐,丁醛,辛醇,季戊四醇,三聚乙醛等重要的化工原料二,用作还原剂及杀菌剂三,主要用于制备醋酸,醋酐,乙酸乙酯,丁醇,季戊四醇,三聚乙醛,3-羟基丁醛,三氯乙醛等产品四,GB 2760―1996规定为暂时允许使用的食用香料.主要用于配制柑橘,苹果,奶油等型香精.五,乙醛的最大用户是乙酸行业,丁醇,辛醇过去也是乙醛的重要衍生产品,现在已基本为丙烯羰基合成法代替.乙醛的其他消费领域是生产季戊四醇,过乙酸,吡啶及其衍生物.国内生产的乙醛基本上都作为生产乙酸的中间体,只有少量用于生产季戊四醇,丁醇,三氯乙醛,三羟甲基丙烷等产品.乙醛可用于生产缩醛,巴豆醛,过氧乙酸,羟基丙腈,三氯乙醛,乙酸乙酯,季戊四醇,乙酐,乙酸,乙二醛,苯基丙烯醛,乙缩醛,甲乙胺,二乙胺,α-丙氨酸,吡啶,α-甲基吡啶,β-甲基吡啶,γ-甲基吡啶.
- 性质描述无色易燃易挥发易流动的液体,有辛辣刺激性气味.熔点-123.5°C,沸点20.16°C,相对密度0.7834(18/4°C),折射率1.3311,闪点(闭杯)-38°C,比热容(25°C)1.41J/(g・°C).可与水,乙醇,乙醚,苯,汽油,甲苯,二甲苯和丙酮混溶.蒸气与空气形成爆炸性混合物,爆炸极限4.0-57.0(体积).临界温度181.5°C(6.32MPa),临界压力6.40MPa.
欧盟法规
统一分类与标签压力设备指令-第1组危险流体REACH注册ECHA物质欧盟气雾剂指令-标签制度食品接触材料-禁用CMR物质工作场所安全标识要求化妆品禁用物质清单C&L通报ECHA物质REACH预注册废弃物危险特性清单上下游产品
CAS号119668-50-7 N,N-二乙基-1H-吲哚-1-羧酰胺 | CAS号105949-28-8 N,N-diethyl-3-(... | CAS号108576-22-3 (E)-3-(5-methyl... | CAS号105542-93-6 1-[1-(1-hydroxy... | CAS号106073-45-4 6-(4-chlorophen... | CAS号104483-32-1 1-bromoethyl ph... | CAS号111887-18-4 4-(4-methoxyphe... | CAS号112031-38-6 2-ethoxy-3,5-di... | CAS号6626-84-2 二甲基亚苄基丙二酸酯 | CAS号1111637-73-0 1-(5-溴-2-氟吡啶-3-基)乙醇合成工艺路线路线简述
- 合成目标产物 Acetaldehyde 主要起始原料 Bromoethane
- (文献来源)合成步骤主要原料 Bromoethane
N-亚硝基二乙胺置于human Cytochrome P450 2Ab,Recombinant Human Cytochrome B5 From Plasmid Pse420(Amp),Recombinant Rat Nadph-P450 Reductase,Glucose-6-Phosphate,Nicotinamide Adenine Dinucleotide Phosphate,1,2-二十二酰基-Sn-Glycero-3-胆碱磷酸,Yeast Glucose-6-Phosphate Dehydrogenase体系中,化学反应 0.25H,反应生成 乙醛
参考文献:人类细胞色素 P450 2A6 氧化 N-亚硝基烷基胺:连续氧化成醛和羧酸以及反应步骤分析.
标题:人类细胞色素 P450 2A6 氧化 N-亚硝基烷基胺:连续氧化成醛和羧酸以及反应步骤分析.
摘要:细胞色素 P450 (P450) 2A6 将亚硝胺,包括 N,N-二甲基亚硝胺 (Dmn) 和 N,N-二乙基亚硝胺 (Den) 激活为烷基重氮氧化物(它们是 Dna 烷基化剂)和醛(来自 Dmn 和 Ch(3)Cho 来自 Den).dmn 的 N-脱烷基化具有很高的固有动力学氘同位素效应((D)K(App) 约 10),这在各种竞争性和非竞争性实验中得到了高度表达.den 的 (D)K(App) 约为 3,在非竞争性实验中未表达.dmn 和 Den 也分别被氧化为 Hco(2)H 和 Ch(3)Co(2)H.在这两种情况下都没有观测到滞后,考虑到测量 Dmn 和 Den 氧化成醛和醛氧化成羧酸的 K(Cat) 和 K(M) 参数,这是出乎意料的.光谱分析没有表明醛对 P450 2A6 有很强的亲和力,但脉冲追踪实验表明,在 Dmn 和 Den 氧化成羧酸的过程中,与添加的(未标记的)醛只有有限的交换.在
DOI:10.1074/jbc.M109.088039
专利信息
专利号:US-11667658-B2
优先权日:2021-06-30
标 题:Chemical synthesis of the organoarsenical antibiotic arsinothricin
发明人:ROSEN BARRY P; YOSHINAGA MASAFUMI; WNUK STANISLAW F; HOWLADER MD ABU HASAN; SUZOL SK MD SAZZAD HOSSAIN
权利人:ROSEN BARRY P; YOSHINAGA MASAFUMI; WNUK STANISLAW F; HOWLADER MD ABU HASAN; SUZOL SK MD SAZZAD HOSSAIN; THE FLORIDA INTERNATIONAL UNIV BOARD OF TRUSTEES
摘要:The subject invention provides methods for the chemical synthesis of racemic arsinothricin (D,L-AST), the novel organoarsenical antibiotic. One is by condensation of the 2-chloroethyl(methyl)arsinic acid with acetamidomalonate, and the second involves reduction of the N-acetyl-protected derivative of hydroxyarsinothricin (AST-OH) and subsequent methylation of the resulting sodium salt of trivalent arsenic intermediate with methyl iodide. The enzyme AST N-acetyltransferase (ArsN1) was utilized to purify L-AST from racemic AST. This expedient chemical synthesis of AST provides a source of this novel antibiotic for future drug development.
专利号:US-6683189-B1
优先权日:1996-02-26
标 题 :Method for the synthesis of pyrrole and imidazole carboxamides on a solid support
发明人:DERVAN PETER B; BAIRD ELDON
权利人:CALIFORNIA INST OF TECHN
摘要:The present invention describes a novel method for the solid phase synthesis of polyamides containing imidazole and pyrrole carboxamides. The polyamides are prepared on a solid support from aromatic carboxylic acids and aromatic amines with high stepwise coupling yields (>99%), providing milligram quantities of highly pure polyamides. The present invention also describes the synthesis of analogs of the natural products Netropsin and Distamycin A, two antiviral antibiotics. The present invention also describes a novel method for the solid phase synthesis of imidazole and pyrrole carboxamide polyamide-oligonucleotide conjugates. This methodology will greatly increase both the complexity and quantity of minor-groove binding polyamides and minor-groove binding polyamide-oligonucleotide conjugates which can be synthesized and tested.
专利号:US-9446995-B2
优先权日:2012-05-21
标 题:Synthesis of therapeutic and diagnostic drugs centered on regioselective and stereoselective ring opening of aziridinium ions
发明人:CHONG HYUN-SOON
权利人:CHONG HYUN-SOON; ILLINOIS INST OF TECH
摘要:Stereoselective and regioselective synthesis of compounds via nucleophilic ring opening reactions of aziridinium ions for use in stereoselective and regioselective synthesis of therapeutic and diagnostic compounds.
专利号:US-10189803-B2
优先权日:2008-02-22
标题 :Synthesis of therapeutic and diagnostic drugs centered on regioselective and stereoselective ring opening of aziridinium ions
发明人:CHONG HYUN-SOON
权利人:CHONG HYUN SOON; ILLINOIS INSTITUTE OF TECH
摘要:Stereoselective and regioselective synthesis of compounds via nucleophilic ring opening reactions of aziridinium ions for use in stereoselective and regioselective synthesis of therapeutic and diagnostic compounds.
专利号:US-9884885-B2
优先权日:2009-05-18
标题:Synthesis of labile base protected-modified deoxy and modified ribo nucleosides, corresponding phosphoramidites and supports and their use in high purity oligonucleotide synthesis
发明人:SRIVASTAVA SURESH C; SRIVASTAVA NAVEEN P
权利人:SRIVASTAVA SURESH C; SRIVASTAVA NAVEEN P; CHEMGENES CORP
摘要:This invention relates to novel method of synthesis of RNA utilizing N-2-acetyl protected guanine as nucleoside base, nucleosides, succinates, phosphoramidites, corresponding solid supports that are suitable for oligo deoxy nucleosides and RNA oligonucleotide synthesis. Our discovery using N-acetyl protected guanine as nucleoside base protecting group, which is significantly faster base labile protecting group, yet significantly more stable than commonly utilized-2-isobutyryl guanosine is a novel approach to obtain highest purity oligonucleotides. This approach is designed to lead to very high purity and very clean oligonucleotide, after efficient removal of the protecting groups, including acetyl group from guanine and to produce high purity therapeutic grade DNA oligonucleotides, RNA oligonucleotides, diagnostic DNA, diagnostic RNA for microarray platform. The deprotection of acetyl protecting groups of the natural deoxy and ribonucleosides occurs under substantially reduced time in contact with mild deprotection conditions such as mild bases, secondary amines for removal of such groups under such conditions would allows synthesis of various DNA and RNA of highest purity for diagnostics and therapeutic application. This approach is designed to lead to high purity large scale therapeutic grade oligonucleotide chimeras which consist of fluoro sugar modification in conjunction with deoxy nucleosides, ribonucleosides, modified base and modified sugar nucleosides. This approach is further designed to use acetyl guanine protecting group when other bases are sensitive nucleoside, and for use in oligo peptide synthesis and for support bound oligo nucleotides.
专利号:WO-2012017400-A1
优先权日:2010-08-03
标 题 :Synthesis of acyl-pantetheine derivatives and the use thereof in the synthesis of acyl-coenzyme a derivatives
发明人:VAN DIJK ALBERDINA AIKE; BADENHORST CHRISTOFFEL PETRUS STEPHANUS
权利人:UNIV NORTHWEST; VAN DIJK ALBERDINA AIKE; BADENHORST CHRISTOFFEL PETRUS STEPHANUS
摘要:The present invention relates to a novel synthesis method for acyl-pantetheine derivatives. The present invention further relates to the use of said synthesized acyl-pantetheine derivatives as a starting material in the enzymatic synthesis of acyl-coenzyme A derivatives. According to a first aspect thereof, the present invention provides a method for the synthesis of acyl-pantetheine derivatives, the method including the steps of: a) providing a source of pantetheine; b) providing a source of acyl ester; and c) contacting the source of pantetheine with the source of acyl ester to form the corresponding acyl-pantetheine derivative, having the general formula (I), wherein R is an acyl group.The present invention also provides a method for the synthesis of acyl-coenzyme A derivatives as well as the use of a source of pantetheine and a source of acyl ester in the preparation steps of these two methods.